People on the Move-July/August

Biopharma Manufacturers Transcept Pharmaceuticals (Point Richmond, CA) has appointed John Kollins as senior vice president and chief business officer. Previously, he was associated with Parnassus Partners, and before that, CEO of Oxigene. Transcept is developing neuroscience products, including its first […]

Read More

What Makes a Pharmaceutical Industry Leader?

The pharmaceutical industry routinely recruits medical doctors (MDs) and researchers from academia, which serves as something of a farm system for the industry. Most of these scientists move into research or medical affairs roles when they join industry. Some of […]

Read More

Reacting to the iPad Buzz

Pharma is eagerly responding to Apple’s iPad. Does this make sense? Yes. And no. Does it make sense for your company to invest in iPads now? What factors should drive your decision? If you decide to jump in, how can […]

Read More

Is There Life After the Lab?

Is there life after the lab? That’s a question that I’ve heard from clients over and over during the last half-dozen years or so. Many pharmaceutical executives have pondered that question and I’m sure scores more are pondering it today. […]

Read More

People on the Move-April

Pfizer is positioning its senior management following the merger with Wyeth Pharmaceuticals. As laid out by CEOs Jeff Kindler and Bernard Poussot, it will form two distinct research organizations, PharmaTherapeutics Research Group for small molecules, and BioTherapeutics Research Group, for […]

Read More

CMR Institute Offers New Sales-Rep Training

CMR Institute (Roanoke, VA), the only nationally recognized training program for certifying medical representatives and managers, has developed a new training program called 4C (for “Core Competencies, Capabilities and Credibility”). It is an addition to the Institute’s programs for certified […]

Read More

People on the Move-March

Mark Altmeyer is now president and CEO of Otsuka American Pharmaceutical, Inc., (Rockville, MD and Princeton, NJ) replacing Dean R. Haubrich, who will now be chairman of the board. Altmeyer joins Otsuka from Bristol Myers Squibb, where he was SVP, […]

Read More